These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10385612

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase.
    Hill PA, Docherty AJ, Bottomley KM, O'Connell JP, Morphy JR, Reynolds JJ, Meikle MC.
    Biochem J; 1995 May 15; 308 ( Pt 1)(Pt 1):167-75. PubMed ID: 7755562
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption.
    Hou P, Troen T, Ovejero MC, Kirkegaard T, Andersen TL, Byrjalsen I, Ferreras M, Sato T, Shapiro SD, Foged NT, Delaissé JM.
    Bone; 2004 Jan 15; 34(1):37-47. PubMed ID: 14751561
    [Abstract] [Full Text] [Related]

  • 9. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases.
    Everts V, Delaissé JM, Korper W, Niehof A, Vaes G, Beertsen W.
    J Cell Physiol; 1992 Feb 15; 150(2):221-31. PubMed ID: 1734028
    [Abstract] [Full Text] [Related]

  • 10. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.
    Andersen TL, del Carmen Ovejero M, Kirkegaard T, Lenhard T, Foged NT, Delaissé JM.
    Bone; 2004 Nov 15; 35(5):1107-19. PubMed ID: 15542036
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.
    Delaissé JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L.
    Microsc Res Tech; 2003 Aug 15; 61(6):504-13. PubMed ID: 12879418
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activators are involved in the degradation of bone by osteoclasts.
    Everts V, Daci E, Tigchelaar-Gutter W, Hoeben KA, Torrekens S, Carmeliet G, Beertsen W.
    Bone; 2008 Nov 15; 43(5):915-20. PubMed ID: 18691680
    [Abstract] [Full Text] [Related]

  • 13. The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors.
    Sato T, Foged NT, Delaissé JM.
    J Bone Miner Res; 1998 Jan 15; 13(1):59-66. PubMed ID: 9443791
    [Abstract] [Full Text] [Related]

  • 14. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts.
    Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Härkönen P, Väänänen HK.
    Endocrinology; 2001 Dec 15; 142(12):5371-8. PubMed ID: 11713237
    [Abstract] [Full Text] [Related]

  • 15. A selective inhibitor of matrix metalloproteinases inhibits the migration of isolated osteoclasts by increasing the life span of podosomes.
    Goto T, Maeda H, Tanaka T.
    J Bone Miner Metab; 2002 Dec 15; 20(2):98-105. PubMed ID: 11862531
    [Abstract] [Full Text] [Related]

  • 16. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
    Henriksen K, Sørensen MG, Nielsen RH, Gram J, Schaller S, Dziegiel MH, Everts V, Bollerslev J, Karsdal MA.
    J Bone Miner Res; 2006 Jan 15; 21(1):58-66. PubMed ID: 16355274
    [Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinase inhibitors block osteoclastic resorption of calvarial bone but not the resorption of long bone.
    Everts V, Korper W, Docherty AJ, Beertsen W.
    Ann N Y Acad Sci; 1999 Jun 30; 878():603-6. PubMed ID: 10415785
    [No Abstract] [Full Text] [Related]

  • 18. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts.
    Sahara T, Itoh K, Debari K, Sasaki T.
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb 30; 270(2):152-61. PubMed ID: 12524690
    [Abstract] [Full Text] [Related]

  • 19. Cathepsins in the osteoclast.
    Goto T, Yamaza T, Tanaka T.
    J Electron Microsc (Tokyo); 2003 Feb 30; 52(6):551-8. PubMed ID: 14756243
    [Abstract] [Full Text] [Related]

  • 20. Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR.
    Ishibashi O, Inui T, Mori Y, Kurokawa T, Kokubo T, Kumegawa M.
    Calcif Tissue Int; 2001 Feb 30; 68(2):109-16. PubMed ID: 11310346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.